By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Axcan Pharma 

597 Laurier Boulevard

Mont-Saint-Hilaire  Quebec  J3H6C4  Canada
Phone: 450-467-5138 Fax: 450-464-9979




Company News
The Newly Combined Axcan Pharma (AXCA) and Eurand Announce Name Change to Aptalis 5/6/2011 6:49:39 AM
Axcan Pharma (AXCA) to Buy Mpex Pharmaceuticals, Inc. for Phase III-Stage Aerosol Antibiotic; Mpex Plans to Spin Out the Aeroquin Assets into a New Company 4/14/2011 10:55:47 AM
Pinnacle Biologics Acquires PHOTOFRIN(R) and PHOTOBARR(R), Novel Photodynamic Therapy for Treating Various Types of Cancer 3/29/2011 8:34:23 AM
Axcan Pharma (AXCA) Completes Acquisition of Eurand and Commences Subsequent Offering Period 2/11/2011 10:16:40 AM
Eurand and Axcan Pharma (AXCA) Announce Extension of the Tender Offer 2/1/2011 8:33:50 AM
Axcan Pharma (AXCA) Announces Proposed Private Offering of $225 Million of Senior Secured Notes and Intent to Amend and Restate Credit Facility 1/26/2011 10:27:24 AM
Axcan Pharma (AXCA) Achieves Cost Savings with Medidata Solutions, Inc. Rave 6/2/2010 10:47:55 AM
Axcan Pharma (AXCA) Presents PYLERA(R)'s European Phase III Trial Results at DDW 2010 4/28/2010 10:51:42 AM
Leading Canadian Pharmaceutical Company Axcan Pharma (AXCA) Selects Emtec, Inc. Subsidiary to Provide Value Based Management Services 3/9/2010 9:46:32 AM
AGI Therapeutics plc Announces Termination of Agreement With Axcan Pharma (AXCA) for AGI-010 8/14/2009 6:48:31 AM